An Ultrasound Contrast Agent Targeted to P-Selectin Detects Activated Platelets at Supra-Arterial Shear Flow Conditions

Objectives:To evaluate targeting of a microbubble contrast agent to platelets under high shear flow using the natural selectin ligand sialyl Lewisa. Materials and Methods:Biotinylated polyacrylamide Sialyl Lewisa or biotinylated carbohydrate-free polymer (used as a control) were attached to biotinylated microbubbles via a streptavidin linker. Activated human platelets were isolated and attached to fibrinogen-coated culture dishes. Fibrinogen-coated dishes without platelets or platelet dishes blocked by an anti-P-selectin antibody served as negative control substrates. Dishes coated by recombinant P-selectin served as a positive control substrate. Microbubble adhesion was assessed by microscopy in an inverted parallel plate flow chamber, with wall shear stress values of 40, 30, 20, 10, and 5 dynes/cm2. The ratio of binding and passing microbubbles was defined as capture efficiency. Results:There was no significant difference between the groups regarding the number of microbubbles in the fluid flow at each shear rate. Sialyl Lewisa-targeted microbubbles were binding and slowly rolling on the surface of activated platelets and P-selectin-coated dishes at all the flow conditions including 40 dynes/cm2. Capture efficiency of targeted microbubbles to activated platelets and recombinant P-selectin decreased with increasing shear flow: at 5 dynes/cm2, capture efficiency was 16.11% on activated platelets versus 21.83% on P-selectin, and, at 40 dynes/cm2, adhesion efficiency was still 3.4% in both groups. There was neither significant adhesion of Sialyl Lewisa-targeted microbubbles to control substrates, nor adhesion of control microbubbles to activated platelets or to recombinant P-selectin. Conclusions:Microbubble targeting using sialyl Lewisa, a fast-binding ligand to P-selectin, is a promising strategy for the design of ultrasound contrast binding to activated platelets under high shear stress conditions.

[1]  J. Serfaty,et al.  In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms , 2010, Investigative radiology.

[2]  Zahi A Fayad,et al.  High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[3]  K. Ley,et al.  Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Matthias Stuber,et al.  Controversies in cardiovascular medicine series Imaging of the unstable plaque : how far have we got ? , 2009 .

[5]  Elmar Spuentrup,et al.  Thrombus Imaging With Fibrin-Specific Gadolinium-Based MR Contrast Agent EP-2104R: Results of a Phase II Clinical Study of Feasibility , 2009, Investigative radiology.

[6]  E. Lancelot,et al.  Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. , 2009, Journal of medicinal chemistry.

[7]  L. Hofstra,et al.  Molecular Imaging of Macrophage Cell Death for the Assessment of Plaque Vulnerability , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[8]  M. Olschewski,et al.  Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.

[9]  Bernd J Pichler,et al.  Radionuclide imaging: a molecular key to the atherosclerotic plaque. , 2008, Journal of the American College of Cardiology.

[10]  Zhi-Yong Li,et al.  Assessment of carotid plaque vulnerability using structural and geometrical determinants. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[11]  Alfons Verbruggen,et al.  Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. , 2008, Cardiovascular research.

[12]  J. Hennig,et al.  Functionalized Magnetic Resonance Contrast Agent Selectively Binds to Glycoprotein IIb/IIIa on Activated Human Platelets under Flow Conditions and Is Detectable at Clinically Relevant Field Strengths , 2008, Molecular imaging.

[13]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[14]  Jie Zheng,et al.  Targeted Contrast Agent Helps to Monitor Advanced Plaque During Progression: A Magnetic Resonance Imaging Study in Rabbits , 2008, Investigative radiology.

[15]  A. Klibanov Ultrasound molecular imaging with targeted microbubble contrast agents , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[16]  Emma M.L. Chung,et al.  Enhanced Detection of Thromboemboli With the Use of Targeted Microbubbles , 2007, Stroke.

[17]  Zahi A Fayad,et al.  Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes , 2007, Journal of magnetic resonance imaging : JMRI.

[18]  Sanjiv S Gambhir,et al.  Cardiovascular molecular imaging. , 2007, Radiology.

[19]  Eric Allémann,et al.  Molecular Imaging of Human Thrombus With Novel Abciximab Immunobubbles and Ultrasound , 2007, Stroke.

[20]  V. Rasche,et al.  Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging. , 2007, Seminars in thrombosis and hemostasis.

[21]  Zahi A Fayad,et al.  Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI , 2007, Proceedings of the National Academy of Sciences.

[22]  S. Acton,et al.  Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. , 2006, Contrast media & molecular imaging.

[23]  S. Acton,et al.  Selectin ligands promote ultrasound contrast agent adhesion under shear flow. , 2006, Molecular pharmaceutics.

[24]  Klaus Ley,et al.  Deformable gas-filled microbubbles targeted to P-selectin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Robert L Wilensky,et al.  Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. , 2006, Journal of the American College of Cardiology.

[26]  Alexander L. Klibanov,et al.  Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.

[27]  William R Wagner,et al.  Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. , 2005, Biotechnology and bioengineering.

[28]  Bruno Brochet,et al.  Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging , 2004, Investigative radiology.

[29]  Klaus Ley,et al.  Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[30]  V. Moy,et al.  Molecular basis of the dynamic strength of the sialyl Lewis X--selectin interaction. , 2004, Chemphyschem : a European journal of chemical physics and physical chemistry.

[31]  R. Cummings,et al.  Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. , 2002, Blood.

[32]  J. Badimón,et al.  The vulnerable plaque and acute coronary syndromes. , 2002, The American journal of medicine.

[33]  E. Unger,et al.  Targeted-Microbubble Binding Selectively to GPIIb IIIa Receptors of Platelet Thrombi , 2002, Investigative radiology.

[34]  M. Gawaz,et al.  A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation , 2002, The Journal of experimental medicine.

[35]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[36]  D. Hammer,et al.  Cell-free rolling mediated by L-selectin and sialyl Lewis(x) reveals the shear threshold effect. , 2000, Biophysical journal.

[37]  P. Dayton,et al.  Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. , 1999, Ultrasound in medicine & biology.

[38]  W. Wagner,et al.  Targeting and ultrasound imaging of microbubble-based contrast agents , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.

[39]  M. Gawaz,et al.  Evaluation of platelet membrane glycoproteins in coronary artery disease : consequences for diagnosis and therapy , 1999, Circulation.

[40]  K. Ley,et al.  Molecular mechanisms of leukocyte recruitment in the inflammatory process. , 1996, Cardiovascular research.

[41]  N. Bovin,et al.  An E-selectin binding assay based on a polyacrylamide-type glycoconjugate. , 1996, Analytical biochemistry.

[42]  T. Kogan,et al.  Structure-function analysis of P-selectin-sialyl LewisX binding interactions. Mutagenic alteration of ligand binding specificity. , 1996, The Journal of biological chemistry.

[43]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[44]  A. Varki,et al.  Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R P McEver,et al.  Role of Selectins in Leukocyte Adhesion to Platelets and Endothelium , 1994, Annals of the New York Academy of Sciences.

[46]  Sylvia,et al.  Higher-affinity oligosaccharide ligands for E-selectin. , 1993, The Journal of clinical investigation.

[47]  T. Watanabe,et al.  High affinity binding of the leucocyte adhesion molecule L-selectin to 3'-sulphated-Le(a) and -Le(x) oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides. , 1992, Biochemical and biophysical research communications.

[48]  K. Lloyd,et al.  Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. , 1989, Cancer research.

[49]  C. Zarins,et al.  Local Effects of Stenoses: Increased Flow Velocity Inhibits Atherogenesis , 1981, Circulation.

[50]  W. Stehbens The role of hemodynamics in the pathogenesis of atherosclerosis. , 1975, Progress in cardiovascular diseases.

[51]  Anna Laskowska,et al.  Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. , 2002, Acta biochimica Polonica.